Correlation Between Mangoceuticals, Common and Nexalin Technology

Can any of the company-specific risk be diversified away by investing in both Mangoceuticals, Common and Nexalin Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangoceuticals, Common and Nexalin Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangoceuticals, Common Stock and Nexalin Technology, you can compare the effects of market volatilities on Mangoceuticals, Common and Nexalin Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangoceuticals, Common with a short position of Nexalin Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangoceuticals, Common and Nexalin Technology.

Diversification Opportunities for Mangoceuticals, Common and Nexalin Technology

-0.32

Correlation Coefficient

Mangoceuticals, Common  Nexalin Technology

Very good diversification

The 3 months correlation between Mangoceuticals, and Nexalin is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Mangoceuticals, Common Stock and Nexalin Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexalin Technology and Mangoceuticals, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangoceuticals, Common Stock are associated (or correlated) with Nexalin Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexalin Technology has no effect on the direction of Mangoceuticals, Common i.e., Mangoceuticals, Common and Nexalin Technology go up and down completely randomly.

Pair Corralation between Mangoceuticals, Common and Nexalin Technology

Given the investment horizon of 90 days Mangoceuticals, Common Stock is expected to generate 0.39 times more return on investment than Nexalin Technology. However, Mangoceuticals, Common Stock is 2.58 times less risky than Nexalin Technology. It trades about 0.16 of its potential returns per unit of risk. Nexalin Technology is currently generating about -0.01 per unit of risk. If you would invest  252.00  in Mangoceuticals, Common Stock on December 24, 2024 and sell it today you would earn a total of  194.00  from holding Mangoceuticals, Common Stock or generate 76.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	85.25%
Values	Daily Returns

Mangoceuticals, Common Stock  vs.  Nexalin Technology

Mangoceuticals, Common

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mangoceuticals, Common Stock are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Mangoceuticals, Common showed solid returns over the last few months and may actually be approaching a breakup point.

Nexalin Technology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Nexalin Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's forward indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Mangoceuticals, Common and Nexalin Technology

The main advantage of trading using opposite Mangoceuticals, Common and Nexalin Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangoceuticals, Common position performs unexpectedly, Nexalin Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will offset losses from the drop in Nexalin Technology's long position.

The idea behind Mangoceuticals, Common Stock and Nexalin Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..